Literature DB >> 12356817

Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, IL-1alpha and TGF-beta.

Julia K L Woodward1, Shona R Elshaw, Anna K Murray, Carmel E Nichols, Neil Cross, David Laws, Ian G Rennie, Karen Sisley.   

Abstract

PURPOSE: To investigate potential factors involved in uveal melanoma migration and invasion in vitro.
METHODS: Using a microchemotaxis chamber, the effects were studied of a range of stimulators and inhibitors on a series of 10 primary uveal melanomas and 2 uveal melanoma cell lines, by assessing invasion through an 8- micro m pore membrane, precoated with an extracellular matrix solution. In addition, invasion in response to the effect of cells and conditioned media derived from the liver and other tissues was studied for one uveal melanoma culture, by using double-chambered wells, and invasion was assessed through an 8- micro m pore membrane, precoated with synthetic extracellular matrix. In all instances, invading cells were counted under x400 magnification on the lower surface of the membrane. Levels of invasion were correlated with histopathologic markers of prognosis.
RESULTS: Conditioned media and cells derived from other tissues, including the liver, increased cellular invasion of the uveal melanoma cell line studied. For specific regulators, maximum stimulation of invasion was induced by hepatic growth factor (HGF), growth-related oncogene (GRO), and macrophage inflammatory protein (MIP)-1beta, whereas significant inhibition was induced by IL-1alpha, TGF-beta1, and TGF-beta2.
CONCLUSIONS: The primary site of metastasis in patients with uveal melanoma is the liver. For the degree of site specificity commonly seen, regulators involved in the process may be expressed at the secondary sites, promoting adhesion, migration, invasion, and proliferation of tumor cells. HGF, GRO, MIP-1beta, IL-1alpha, TGF-beta1, and TGF-beta2 may play a significant role in regulating invasion of uveal melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12356817

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.

Authors:  Pierre L Triozzi; Wayne Aldrich; Arun Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

2.  The identification of chromosome abnormalities associated with the invasive phenotype of uveal melanoma in vitro.

Authors:  Neil A Cross; Ian G Rennie; Anna K Murray; Karen Sisley
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting.

Authors:  Stacey L Hembruff; Nikki Cheng
Journal:  Cancer Ther       Date:  2009-04-14

4.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

5.  In vivo effects of lattice radiation therapy on local and distant lung cancer: potential role of immunomodulation.

Authors:  Saravana Kanagavelu; Seema Gupta; Xiaodong Wu; Sakhi Philip; Max M Wattenberg; James W Hodge; Mariluz D Couto; Kristina D Chung; Mansoor M Ahmed
Journal:  Radiat Res       Date:  2014-07-18       Impact factor: 2.841

6.  Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma.

Authors:  Sarah J Storr; Sabreena Safuan; Angana Mitra; Faye Elliott; Christopher Walker; Mark J Vasko; Bernard Ho; Martin Cook; Rabab A A Mohammed; Poulam M Patel; Ian O Ellis; Julia A Newton-Bishop; Stewart G Martin
Journal:  Mod Pathol       Date:  2011-11-11       Impact factor: 7.842

7.  The role of c-kit and imatinib mesylate in uveal melanoma.

Authors:  Patricia Rusa Pereira; Alexandre Nakao Odashiro; Jean Claude Marshall; Zelia Maria Correa; Rubens Belfort; Miguel N Burnier
Journal:  J Carcinog       Date:  2005-10-19

8.  Expression and migratory analysis of 5 human uveal melanoma cell lines for CXCL12, CXCL8, CXCL1, and HGF.

Authors:  Jean-Claude Marshall; Patrick Logan; Emilia Antecka; Dana Faingold; Shawn C Maloney; Miguel N Burnier; Sebastian Di Cesare
Journal:  J Carcinog       Date:  2007-01-29

9.  Gene expression regulation by agonist-independent constitutive signaling of melanocortin-1 receptor.

Authors:  Ikjoo Seong; Jaesang Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-06-26

10.  Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma.

Authors:  Pierre L Triozzi; Susan Achberger; Wayne Aldrich; John W Crabb; Yogen Saunthararajah; Arun D Singh
Journal:  Clin Epigenetics       Date:  2016-07-22       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.